We need your help.
For 25 years Angiogenesis Foundation has worked to bring life-changing medical innovation to previously untreatable illnesses. Now, we lead the collaborative efforts to treat both the acute and long-lasting effects of COVID-19.
We need your support now more than ever. In a time of fear and uncertainty, trusted science offers us resilience and hope. Be part of our mission and help make the impossible possible.
Donate today and give the gift of health.
Dr. William Li Talks Long Hauler Syndrome with Rachael Ray
Millions of Lives Impacted
News & Press
FDA approves faricimab for treatment of wet AMD and DME
Faricimab will be the first and only FDA-approved medicine targeting two distinct pathways, Ang-2 and VEGF-A, involved in retinal diseases and may cause vision loss.
It’s time to focus on potential long-term organ damage from covid-19
William Li is president of the Angiogenesis Foundation and author of “Eat to Beat Disease.” Andrew von Eschenbach is former commissioner of the U.S. Food and Drug Administration and former director of the National Cancer Institute. New cases of covid-19 are...
New Study Published in the New England Journal of Medicine Shows COVID-19 Causes Blood Vessel Damage
Vascular effects of the virus explain the dangerous blood clotting seen in patients. CAMBRIDGE, Mass., May 21, 2020 /PRNewswire/ -- The Angiogenesis Foundation reports today that new research published in the New England Journal of Medicine shows that the respiratory...
Angiogenesis Foundation President and CEO Dr. William Li’s EAT TO BEAT DISEASE Achieves New York Times Bestseller Status
The Angiogenesis Foundation Celebrates the Life-Changing Guide to More Than 200 Foods That Can Help Prevent, Treat, and Reverse Disease Cambridge, MA - The Angiogenesis Foundation announced today its President and CEO Dr. William Li’s highly-praised book, EAT TO BEAT...
The Angiogenesis Foundation Reports New Protocol for Stopping a Deadly Brain Tumor Using Repurposed Drugs
Using a combinatorial approach of existing FDA-approved drugs, the researchers effectively stopped glioblastoma (GBM) progression in lab studies Cambridge, MA - The Angiogenesis Foundation presented data today at the AACR Annual Meeting 2019 in Atlanta, GA, from new...
We are change-makers, educators, and advocates.
The Angiogenesis Foundation is the leading nonprofit organization disrupting disease through angiogenesis, the process the body uses to grow new blood vessels. For more than 20 years, we have championed angiogenesis-based science to improve world health. Our mission is to improve global health by advancing angiogenesis-based medicine, diet, and lifestyle. Learn more about us.
A Message From Sir Roger Moore